Sorafenib for Desmoid Tumors Ups Progression-Free Survival
THURSDAY, Dec. 20, 2018 — Sorafenib prolongs progression-free survival among patients with desmoid tumors, according to a study published in […]
(HealthDay)—For young adults hospitalized for injury, the first year of implementation of Medicaid expansion under the Affordable Care Act correlated […]ups
Medicaid expansion ups access to rehab in young adults with injury